Savvy Updates, 10/11/21: Omnipod 5 Impressive, (2) Medtronic Pump Recalls, Mannkind’s Afrezza Trial for Peds, Non-Invasive CGMs: GraphWear & KnowU, Medicare Drug Pricing under Review, Kidney Disease Research

Savvy Updates, 10/11/21: Omnipod 5 Impressive, (2) Medtronic Pump Recalls, Mannkind’s Afrezza Trial for Peds, Non-Invasive CGMs: GraphWear & KnowU, Medicare Drug Pricing under Review, Kidney Disease Research
type 2 diabetes can be reversed

Savvy Updates, 10/11/21:  Omnipod 5 Impressive, (2) Medtronic Pump Recalls, Mannkind’s Afrezza Trial for Peds, Non-Invasive CGMs: GraphWear & KnowU, Medicare Drug Pricing under Review, Kidney Disease Research

FDA Approval of Omnipod 5 Looks More Promising with Impressive Trial Results was reported by Andrew Briskin for diaTribe.org, 4 October 2021.  The recent release of clinical trial results shows that Omnipod 5, an automated insulin delivery (AID) system, can significantly increase Time in Range and reduce stress around managing diabetes.

At the European Association for the Study of Diabetes (EASD) 2021 conference, experts discussed the positive impacts of using Omnipod 5, highlighted by encouraging results from the latest clinical trial data published in Diabetes Care.

The Savvy Diabetic
thesavvydiabetic
type 2 diabetes can be reversed

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *